Literature DB >> 26993061

Accounting for selection and correlation in the analysis of two-stage genome-wide association studies.

David S Robertson1, A Toby Prevost2, Jack Bowden3.   

Abstract

The problem of selection bias has long been recognized in the analysis of two-stage trials, where promising candidates are selected in stage 1 for confirmatory analysis in stage 2. To efficiently correct for bias, uniformly minimum variance conditionally unbiased estimators (UMVCUEs) have been proposed for a wide variety of trial settings, but where the population parameter estimates are assumed to be independent. We relax this assumption and derive the UMVCUE in the multivariate normal setting with an arbitrary known covariance structure. One area of application is the estimation of odds ratios (ORs) when combining a genome-wide scan with a replication study. Our framework explicitly accounts for correlated single nucleotide polymorphisms, as might occur due to linkage disequilibrium. We illustrate our approach on the measurement of the association between 11 genetic variants and the risk of Crohn's disease, as reported in Parkes and others (2007. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat. Gen. 39: (7), 830-832.), and show that the estimated ORs can vary substantially if both selection and correlation are taken into account.
© The Author 2016. Published by Oxford University Press.

Entities:  

Keywords:  Correlated outcomes; Genome-wide scan; Selection bias; Two-stage sample; Uniformly minimum variance conditionally unbiased estimator

Mesh:

Year:  2016        PMID: 26993061      PMCID: PMC5031943          DOI: 10.1093/biostatistics/kxw012

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  26 in total

1.  Two-Stage sampling designs for gene association studies.

Authors:  Duncan Thomas; Rongrong Xie; Mulugeta Gebregziabher
Journal:  Genet Epidemiol       Date:  2004-12       Impact factor: 2.135

2.  Testing and estimation in flexible group sequential designs with adaptive treatment selection.

Authors:  Martin Posch; Franz Koenig; Michael Branson; Werner Brannath; Cornelia Dunger-Baldauf; Peter Bauer
Journal:  Stat Med       Date:  2005-12-30       Impact factor: 2.373

3.  Selection and bias--two hostile brothers.

Authors:  Peter Bauer; Franz Koenig; Werner Brannath; Martin Posch
Journal:  Stat Med       Date:  2010-01-15       Impact factor: 2.373

4.  Conditional estimation after a two-stage diagnostic biomarker study that allows early termination for futility.

Authors:  Joseph S Koopmeiners; Ziding Feng; Margaret Sullivan Pepe
Journal:  Stat Med       Date:  2012-01-12       Impact factor: 2.373

5.  Methodological Issues in Multistage Genome-wide Association Studies.

Authors:  Duncan C Thomas; Graham Casey; David V Conti; Robert W Haile; Juan Pablo Lewinger; Daniel O Stram
Journal:  Stat Sci       Date:  2009-11-01       Impact factor: 2.901

6.  Two-stage designs for gene-disease association studies with sample size constraints.

Authors:  Jaya M Satagopan; E S Venkatraman; Colin B Begg
Journal:  Biometrics       Date:  2004-09       Impact factor: 2.571

7.  Two-stage designs for gene-disease association studies.

Authors:  Jaya M Satagopan; David A Verbel; E S Venkatraman; Kenneth E Offit; Colin B Begg
Journal:  Biometrics       Date:  2002-03       Impact factor: 2.571

8.  Correcting for bias in the selection and validation of informative diagnostic tests.

Authors:  David S Robertson; A Toby Prevost; Jack Bowden
Journal:  Stat Med       Date:  2015-02-01       Impact factor: 2.373

9.  Unbiased estimation of odds ratios: combining genomewide association scans with replication studies.

Authors:  Jack Bowden; Frank Dudbridge
Journal:  Genet Epidemiol       Date:  2009-07       Impact factor: 2.135

10.  An integrated map of genetic variation from 1,092 human genomes.

Authors:  Goncalo R Abecasis; Adam Auton; Lisa D Brooks; Mark A DePristo; Richard M Durbin; Robert E Handsaker; Hyun Min Kang; Gabor T Marth; Gil A McVean
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

View more
  5 in total

1.  Point and interval estimation in two-stage adaptive designs with time to event data and biomarker-driven subpopulation selection.

Authors:  Peter K Kimani; Susan Todd; Lindsay A Renfro; Ekkehard Glimm; Josephine N Khan; John A Kairalla; Nigel Stallard
Journal:  Stat Med       Date:  2020-05-03       Impact factor: 2.373

2.  Unbiased estimation in seamless phase II/III trials with unequal treatment effect variances and hypothesis-driven selection rules.

Authors:  David S Robertson; A Toby Prevost; Jack Bowden
Journal:  Stat Med       Date:  2016-04-21       Impact factor: 2.373

3.  Stepwise approach to SNP-set analysis illustrated with the Metabochip and colorectal cancer in Japanese Americans of the Multiethnic Cohort.

Authors:  John Cologne; Lenora Loo; Yurii B Shvetsov; Munechika Misumi; Philip Lin; Christopher A Haiman; Lynne R Wilkens; Loïc Le Marchand
Journal:  BMC Genomics       Date:  2018-07-09       Impact factor: 3.969

4.  Point estimation following two-stage adaptive threshold enrichment clinical trials.

Authors:  Peter K Kimani; Susan Todd; Lindsay A Renfro; Nigel Stallard
Journal:  Stat Med       Date:  2018-05-31       Impact factor: 2.373

5.  Conditionally unbiased estimation in the normal setting with unknown variances.

Authors:  David S Robertson; Ekkehard Glimm
Journal:  Commun Stat Theory Methods       Date:  2018-01-05       Impact factor: 0.893

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.